CFD:er är komplexa instrument som innebär hög risk att du förlorar pengar snabbt på grund av hävstången. 77,3% av icke-professionella investerares konton förlorar pengar när de handlar med CFD:er hos den här leverantören. Du bör överväga om du förstår hur CFD:er fungerar och om du har råd att ta den höga risken att förlora dina pengar.

Close

JnJ realtidsdiagram

Instrumentfundament

Weekly Search
Weekly
Daily
Datum Stäng Förändring Förändring (%) Öppna Hög Låg

JnJ news

Tommy Yap 2025 Apr 12, 16:00

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Forex Indices
ECB set to cut rates for the third time this year
Neil Wilson 2024 Oct 10, 16:00

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Forex Indices
US earnings season kicks off, ECB expected to hold rates steady
Neil Wilson 2024 Jul 11, 21:00

Week ahead: US earnings season kicks off, ECB hold expected

Forex Indices
Oil steady, gold bearish trend
Neil Wilson 2024 Jan 22, 08:15

Europe Tries to Ride on US Coat-tails

Stocks Forex Commodities Indices
The Bank of Japan
Neil Wilson 2024 Jan 18, 08:07

Week ahead: ECB, BoJ rate decisions + Tesla earnings on tap

Forex Indices

Senaste nyheter

Visa mer
Frances Wang 2025 Jun 12, 16:00

Stellar (XLM) Price Analysis: Where could XLM go in the upcoming days?

Stocks
Frances Wang 2025 Jun 12, 16:00

Crypto News Today: Bitcoin Price Down 1.85% as US PPI Rises

Cryptocurrencies
Ghko B 2025 Jun 12, 16:00

Dogecoin Price Prediction: Could Dogecoin Price Surge to $0.95?

Cryptocurrencies
Tommy Yap 2025 Jun 12, 16:00

Morning Note: Middle East Conflict Shakes Markets as Oil Soars, While AI Sector Eyes Growth

Morning Note Oil NVDA Tech
Ghko B 2025 Jun 11, 16:00

Crypto Market Sentiment: Crypto Fear and Greed Index Today

Cryptocurrencies
Tommy Yap 2025 Jun 11, 16:00

Morning Note: Adobe’s AI Momentum Leads Market Moves with Gold and Fed in Focus

Morning Note Gold Commodities Stocks
Ghko B 2025 Jun 10, 16:00

BTC USD Price Prediction: How much will Bitcoin be worth in 2030?

Cryptocurrencies
Ghko B 2025 Jun 10, 16:00

Wells Fargo Stock Slides 1.32%: Is Wells Fargo stock a good buy now?

Stocks

Info

Spread

0.95

Spread (%)

0.6084 %

Hävstångseffekt

1:2

Köp till dagslåneränta

-0.0597 %

Sälj till dagslåneränta

-0.0292 %

Valuta

USD

Handelstider

Marknaderna är stängda

Fredag

13:31 - 19:59

Måndag

13:31-19:59

Tisdag

13:31-19:59

Onsdag

13:31-19:59

Torsdag

13:31-19:59

Analys och statistik

Öppna

---

Föregående stängning

---

52 veckors högsta/lägsta

--- – ---

Marknadsvärde

373566406656

Utelöpande aktier

2406070016

Rapportdatum (nästa)

2001-06-13

Utd-procent

2025-06-10

Datum efter utdelning

2025-05-27

Förväntad framtida årlig utdelningsprocent

5.2

Förväntad framtida årlig direktavkastning

0.0335

Vinst per aktie

8.93

Läs mer om detta instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Läs mer om detta instrument

Tillgång
Sälj
Köp
Förändring (%)
Relaterade instrument

latest_education_articles

Visa mer
Trustpilot